Arcus Biosciences Inc (RCUS) returns
Arcus Biosciences returns over 5 years
$1,000 invested in Arcus Biosciences five years ago was worth $543.96 at the close on October 30, 2026, with dividends reinvested: an average return of -11.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -29.6% | — | $704.22 | -0.9% |
| 3 months | -35.6% | — | $643.89 | +2.1% |
| Year to date | -23.7% | — | $763.32 | +11.7% |
| 1 year | -9.9% | — | $900.94 | +12.4% |
| 3 years | +21.7% | +6.8% | $1,217 | +88.5% |
| 5 years | -45.6% | -11.5% | $543.96 | +76.0% |
Arcus Biosciences return by calendar year
| Year | RCUS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -23.7% | +11.7% | -35.4% |
| 2025 | +60.0% | +17.7% | +42.3% |
| 2024 | -22.0% | +24.9% | -46.9% |
| 2023 | -7.6% | +26.2% | -33.8% |
| 2022 | -48.9% | -18.2% | -30.7% |
| 2021 | +55.9% | +28.7% | +27.1% |
| 2020 | +157.0% | +18.4% | +138.7% |
| 2019 | -6.2% | +31.2% | -37.4% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RCUS financials
No forecast, no recommendation. This page describes Arcus Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.